
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES172
A post hoc analysis of the ASCOT-LLA study290 found a significantly lower incidence of CV events in the subpopulation of people with Type 2 diabetes treated with atorvastatin 10 mg when compared with those receiving placebo. (Hazard ratio 0.77, 95% CI 0.61 to 0.98, p<0.036.) Level 1+

[@Poulter_2005]

